Does Oscar Health Cover Vyvanse?
The verdict
Covered on most plans
Oscar Health covers Vyvanse on commercial and ACA/Individual plans — generic lisdexamfetamine, FDA-approved in August 2023, is now the formulary-preferred option via Oscar's PBM, while brand Vyvanse is non-preferred as generic supply improves. A Schedule II 70 mg/day quantity limit and documented ADHD diagnosis are required. Oscar's per-plan drug tiers are not published at the drug level — use the Oscar drug lookup tool or call member services to verify your specific plan.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Oscar Health using your member ID.
Key facts
Generic lisdexamfetamine was FDA-approved in August 2023; the DEA set the 2026 lisdexamfetamine production quota at 51.3 million grams (effective January 2026) to ramp up supply.
FDA ANDA records; DEA Final Order effective January 5, 2026
Brand Vyvanse costs ~$400–$558/month without insurance; generic lisdexamfetamine costs ~$200–$360/month, or as low as ~$60–$70 with a coupon.
Takeda patient assistance; GoodRx cash price data
Vyvanse is the only Schedule II stimulant FDA-approved for both ADHD and moderate-to-severe binge-eating disorder in adults.
FDA Drug Label — Vyvanse (lisdexamfetamine dimesylate)
Medicare vs. commercial coverage
Whether Oscar Health covers Vyvanse depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Oscar has limited Medicare presence. Where Oscar Medicare plans are offered, generic lisdexamfetamine is covered under Medicare Part D with a Schedule II quantity limit; brand Vyvanse may require prior authorization. Medicare beneficiaries cannot use manufacturer savings cards. Verify on your Oscar Medicare plan drug list.
Commercial / Employer
Group & marketplace plans
On Oscar Commercial/Small Group and ACA/Individual plans (Oscar's core book), generic lisdexamfetamine is the formulary-preferred option via Oscar's PBM; brand Vyvanse is non-preferred. A Schedule II 70 mg/day quantity limit applies. Oscar has limited Medicaid presence; where select-state Medicaid is offered, generic lisdexamfetamine is covered per state PDL with PA and QL requirements. Oscar does not publish per-drug tier data at the plan level — verify via the Oscar drug lookup tool at oscarhealth.com or call member services.
The 5 boxes you must tick to get approved
Commercial plans that will consider Vyvanse require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Vyvanse actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Generic lisdexamfetamine: ~$200–$360 per month cash (as low as ~$60–$70 with GoodRx coupon). Brand Vyvanse: ~$400–$558 per month. Estimates only — varies by pharmacy and dose.
List price with no coverage — before any manufacturer savings card.
With coverage
Generic: preferred-tier copay via Oscar's PBM (plan-specific; not published per-drug — verify via Oscar drug lookup). Brand Vyvanse: higher non-preferred tier copay. Exact cost-share depends on your specific Oscar plan benefit design.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates. Oscar does not publish per-drug tier copay data at the plan level — verify on the Oscar drug lookup at oscarhealth.com or by calling member services. Cash price estimates are from GoodRx and SingleCare and vary by pharmacy and coupon availability.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use the Oscar drug lookup tool
Go to oscarhealth.com, log in to your member account, and use the drug search tool to look up 'lisdexamfetamine' or 'Vyvanse.' The tool shows your plan's specific tier, quantity limit, and any prior-authorization requirement. Oscar does not publish per-drug tier data publicly — this member-authenticated lookup is the only way to verify your specific plan's coverage.
- 2
Call Oscar Member Services
Call the number on the back of your Oscar health card to confirm whether generic lisdexamfetamine or brand Vyvanse is covered on your specific plan, what your out-of-pocket copay would be, and whether prior authorization is required.
- 3
Ask your prescriber to submit PA and check pharmacy stock
If prior authorization is needed, your prescriber can submit it through Oscar's digital PA portal or fax system, providing your ADHD (or BED) diagnosis and clinical documentation. Also ask your pharmacy about current generic lisdexamfetamine stock — the stimulant shortage means supply varies; a shortage-documented PA can allow brand dispensing if the generic is unavailable.
Options if Oscar Health won't cover Vyvanse
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic lisdexamfetamine
The formulary-preferred option. FDA-approved in August 2023, generic lisdexamfetamine is therapeutically equivalent to brand Vyvanse and available at a significantly lower cash price (~$60–$70/month with coupon vs. $400–$558 for brand).
Generic amphetamine/dextroamphetamine (Adderall generic)
FDA-approved for ADHD. The generic is typically preferred at a low tier on Oscar commercial plans with a ~60 mg/day QL. The older amphetamine-salts shortage has eased somewhat since the 2022 peak but availability still varies.
Generic methylphenidate (Ritalin)
Non-amphetamine Schedule II stimulant for ADHD. Generally covered at a low tier and may be useful when lisdexamfetamine supply is constrained.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Oscar covers both, but generic lisdexamfetamine is now the formulary-preferred option via Oscar's PBM, and brand Vyvanse is non-preferred. In 2024, Oscar and other insurers temporarily added brand Vyvanse back to formularies because generic supply was thin during the stimulant shortage — those add-backs are being reversed as generic availability improves in 2025–2026. If you need brand Vyvanse, your prescriber will likely need to submit a formulary exception. Verify your specific plan's current status via the Oscar drug lookup.
Oscar applies a Schedule II quantity limit of 70 mg per day for lisdexamfetamine (Vyvanse), consistent with the FEP standard for this drug class. Prescriptions exceeding 70 mg/day trigger additional clinical review and typically require prior authorization. Your prescriber should confirm the QL before submitting a prescription above the standard dose. Oscar's per-plan formulary tool is the authoritative source for your specific plan's exact limit — verify via the Oscar drug lookup or member services.
During the stimulant shortage that intensified in 2023–2024, generic lisdexamfetamine supply was inconsistent even after FDA approval in August 2023. Oscar and many other insurers temporarily added brand Vyvanse back to preferred formulary positions to ensure members could get filled. As generic lisdexamfetamine manufacturing ramped up following the DEA's 2025 quota increases — culminating in the 2026 lisdexamfetamine APQ of 51.3 million grams — plans are reversing those temporary add-backs. Brand Vyvanse is returning to non-preferred status; the generic is the preferred option going forward.
Oscar's digital member tools support prior-authorization requests and prescription management — a genuine differentiator for its tech-forward membership. Schedule II stimulant PAs require prescriber submission, but Oscar's digital PA portal allows prescribers and members to initiate and track requests online or through the app, rather than through a traditional fax-only process. Contact Oscar member services to confirm the PA submission pathway for your specific plan.
Vyvanse (lisdexamfetamine) is FDA-approved for both ADHD and moderate-to-severe binge-eating disorder in adults — the only Schedule II stimulant with the BED indication. Coverage for the BED indication depends on your specific Oscar plan and prior-authorization criteria. Some plans cover Vyvanse for BED with a documented diagnosis; others require ADHD as the covered indication. Check your Oscar plan formulary or call member services to confirm whether the BED indication is covered under your benefit design.
Related Articles
Does Oscar Health Cover Propecia? Hair Loss 2026 | Curex
Oscar Health does not cover Propecia for hair loss — cosmetic exclusion applies. Finasteride 5 mg (Proscar) IS covered as a Tier 1 generic for BPH.
Read moreDoes Oscar Health Cover Farxiga? Coverage & Cost 2026
Yes — Oscar covers Farxiga on commercial and ACA plans; metformin-first step likely. Tier not public — use Oscar app. Generic dapagliflozin now available.
Read moreDoes Oscar Health Cover Ozempic? 2026 Coverage Guide | Curex
Oscar covers Ozempic for T2D with prior auth — never for weight loss. ACA plan formulary, PA steps, NovoCare card, and 2026 cost facts explained.
Read moreDoes Oscar Health Cover Eliquis? Coverage & Cost 2026
Yes — Oscar Health covers Eliquis for AFib and VTE on commercial and ACA plans. Tier unpublished — use Oscar's drug lookup. IRA price $231 for Medicare.
Read moreDoes Oscar Health Cover Contrave? 2026 ACA Guide | Curex
Oscar marketplace plans frequently exclude Contrave. Where covered, BMI prior auth applies. CurAccess ~$99/mo beats the retail price for most members.
Read moreDoes Oscar Health Cover Adderall? 2026 Coverage Guide | Curex
Oscar Health covers Adderall via its PBM — generic preferred low-tier, brand non-preferred. Tier not published; use Oscar drug lookup to confirm.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Oscar Health before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.